CVS Health Co. (NYSE:CVS) Shares Sold by Lester Murray Antman dba SimplyRich

Lester Murray Antman dba SimplyRich trimmed its position in CVS Health Co. (NYSE:CVS) by 26.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,065 shares of the pharmacy operator’s stock after selling 2,935 shares during the period. Lester Murray Antman dba SimplyRich’s holdings in CVS Health were worth $362,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Kentucky Trust Co purchased a new position in shares of CVS Health in the fourth quarter worth about $696,000. Polaris Capital Management LLC increased its holdings in CVS Health by 7.6% in the 4th quarter. Polaris Capital Management LLC now owns 489,500 shares of the pharmacy operator’s stock worth $21,974,000 after buying an additional 34,700 shares during the period. Stonebridge Financial Group LLC purchased a new position in CVS Health during the 4th quarter worth approximately $28,000. Bristlecone Advisors LLC lifted its stake in CVS Health by 4.3% during the 4th quarter. Bristlecone Advisors LLC now owns 10,788 shares of the pharmacy operator’s stock valued at $484,000 after acquiring an additional 448 shares during the period. Finally, Newbridge Financial Services Group Inc. acquired a new stake in shares of CVS Health in the fourth quarter worth $111,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CVS shares. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. Evercore ISI boosted their price objective on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. UBS Group dropped their target price on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a report on Tuesday. Piper Sandler decreased their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday, November 25th. Finally, Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $67.78.

CVS Health Trading Up 1.3 %

Shares of CVS Health stock opened at $55.01 on Wednesday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The firm’s 50-day moving average price is $50.69 and its 200 day moving average price is $55.95. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $69.23 billion, a PE ratio of 13.96, a P/E/G ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. On average, sell-side analysts predict that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.84%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.